Advertisement
New Zealand markets closed
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NZD/USD

    0.5887
    -0.0019 (-0.32%)
     
  • NZD/EUR

    0.5525
    -0.0019 (-0.35%)
     
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • OIL

    83.06
    +0.33 (+0.40%)
     
  • GOLD

    2,409.90
    +11.90 (+0.50%)
     
  • NASDAQ

    17,022.93
    -371.39 (-2.14%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • Dow Jones

    37,902.65
    +127.27 (+0.34%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • NZD/JPY

    90.9830
    -0.2710 (-0.30%)
     

Vertex Pharmaceuticals (VRTX) Q4 2022 Earnings Call Transcript

Vertex Pharmaceuticals (VRTX) Q4 2022 Earnings Call Transcript

My name is Susie Lisa, and as the senior vice president of investor relations for Vertex, it is my pleasure to welcome you to our fourth quarter and full year 2022 financial results conference call. On tonight's call, making prepared remarks, we have Dr. Reshma Kewalramani, Vertex' CEO and president; Stuart Arbuckle, chief operating officer; and Charlie Wagner, chief financial officer.